Clover Health Q3 revenue up 50% YoY to $497M, but cuts FY25 adjusted EBITDA guidance to $15M-$30M

CLOVER HEALTH INVESTMENTS, CORP. /DE

Q3 GAAP net loss $24.4M; revenue $496.7M vs $331M YoY; membership 109,226 (+35% YoY).
Adjusted EBITDA Q3 $2.1M; YTD $45M; FY guidance cut to $15M-$30M from prior $50M-$70M.
Insurance BER Q3 93.5%; full-year BER guidance raised to 90%-91% from 88.5%-89.5%.
Revised FY25 insurance revenue guidance up to $1.850B-$1.880B; midpoint +39% YoY.
Management cites new member mix and elevated utilization; sees 2026 tailwinds from 4-star payment and CMS rate.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.